LATITUDE Pharmaceuticals Inc. Press Releases

• Published on May 6, 2020 - 05:59 GMT

  LATITUDE Pharmaceuticals Develops an SC/IM Injectable Remdesivir Formulation

  100 mg/mL Formulation Offers Significant Advantages for Dosing COVID-19 Patients SAN DIEGO, CALIFORNIA, US, May 5, 2020 /⁨EINPresswire.com⁩/ -- LATITUDE Pharmaceuticals Inc. (LATITUDE), a specialized drug formulation developer, announced today that it has …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on May 7, 2019 - 09:52 GMT

  LATITUDE Pharmaceuticals Receives Notice of Allowance for U.S. Patent Covering Stabile Aqueous Vancomycin Formulations

  "Intra-V" is LATITUDE's stable liquid formulation of the antibiotic vancomycin for injection, with all components FDA-approved and with no safety warnings SAN DIEGO, CA, US, May 7, 2019 /⁨EINPresswire.com⁩/ -- LATITUDE Pharmaceuticals Inc., …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on January 18, 2019 - 00:07 GMT

  LATITUDE Pharmaceuticals Receives Notice of Allowance for U.S. Patent Covering Stabilized Aqueous Glucagon Formulations

  Patent Application Covers Glucagon Formulations for Use with Insulin Pumps and Artificial Pancreas SAN DIEGO, CA, US, January 17, 2019 /⁨EINPresswire.com⁩/ -- LATITUDE Pharmaceuticals Inc., a specialized formulation developer for the biotech and pharma …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...